BIO Asia International Conference

The BIO Asia International Conference brings together the global biotechnology and pharmaceutical industry to explore licensing collaborations and investor engagement in the current Asia-Pacific business and policy environments. Gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market. 

View 2019 Conference Overview 

Download a list of presenting companies sortable by therapeutic focus and phase of development. Interested in presenting? Click here to learn more and join ACT Genomics, BioInvent International AB, Boston Pharmaceuticals, CanBas Co., Ltd., Cidara Therapeutics, Daré Bioscience, GEXVal Inc., HanaVax, iHeart Japan Corporation, Jiangsu Atom Bioscience and Pharmaceutical Co. and more.

Join the conversation! Twitter: #BIOASIA19 | LinkedIn: BIO Asia Group

Sign up to receive updates about this conference: click here.